All-trans retinoic acid induces autophagic degradation of ubiquitin-like modifier activating enzyme 3 in acute promyelocytic leukemia cells.

Huanling Cao,Jing Xie,Lu Guo,Kun Han,Yujun Pei,Xin Li,Guihua Qiu,Jiayang Jin,Lei Hua,Zhaofei Jing,Huifang Wu,Jian Liu,Jing Wang,Beifen Shen,Suoqin Tang,Jiyan Zhang,Jun Zhang,Hu Chen,Qingyang Wang

DOI: https://doi.org/10.1080/10428194.2017.1365850

2018-01-01

Leukemia & Lymphoma

Abstract:All-trans retinoic acid (ATRA) has demonstrated notable success in the treatment of acute promyelocytic leukemia (APL) by inducing granulocytic differentiation. The underlying mechanisms of ATRA therapeutic effects have not been entirely clarified. Here, we reported that the regulation of neddylation, a ubiquitination-like post-translational modification, was involved in the treatment of ATRA on APL. Treating APL cells with ATRA led to the degradation of UBA3, a subunit of neddylation E1. Lysosome-autophagy pathway but not proteasome pathway was responsible for the degradation of UBA3. Neddylation suppression in APL cells was capable of inducing apoptosis, differentiation and proliferation inhibition, suggesting a pivotal role of neddylation in APL cells. ATRA treatment also led to UBA3 degradation in primary APL cells. Taken together, our findings indicated that neddylation was important to maintain the malignant features of APL cells, and suppression of neddylation was involved in the effects of ATRA on APL cells.